SAN DIEGO--(BUSINESS WIRE)--Jan. 3, 2006--AVANIR Pharmaceuticals (AMEX:AVN) announced today that a Phase I study has been initiated in partnership with AstraZeneca UK Limited (AstraZeneca) to...
SAN DIEGO--(BUSINESS WIRE)--Dec. 16, 2005--AVANIR Pharmaceuticals (AMEX:AVN) today announced it has obtained commitments to purchase $20.0 million of its common stock in a registered-direct...
SAN DIEGO--(BUSINESS WIRE)--Dec. 5, 2005--AVANIR Pharmaceuticals (Amex:AVN) today reported unaudited financial results for the quarter and fiscal year ended September 30, 2005. Fiscal Year 2005...
SAN DIEGO--(BUSINESS WIRE)--Nov. 30, 2005--AVANIR Pharmaceuticals (AMEX:AVN) will webcast its quarterly conference call on Monday, December 5, 2005, at 1:30 p.m. Pacific/4:30 p.m. Eastern. The call...